Published in Nature on June 25, 2008
Crystal structure of the β2 adrenergic receptor-Gs protein complex. Nature (2011) 13.92
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science (2008) 11.74
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science (2010) 10.30
Structure of a nanobody-stabilized active state of the β(2) adrenoceptor. Nature (2011) 9.61
The structure and function of G-protein-coupled receptors. Nature (2009) 8.08
Structure of an agonist-bound human A2A adenosine receptor. Science (2011) 6.21
Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science (2010) 5.86
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74
Molecular signatures of G-protein-coupled receptors. Nature (2013) 5.19
Structure of the human κ-opioid receptor in complex with JDTic. Nature (2012) 5.18
Femtosecond protein nanocrystallography-data analysis methods. Opt Express (2010) 4.64
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature (2011) 4.60
The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor. Nature (2011) 4.31
Structure-function of the G protein-coupled receptor superfamily. Annu Rev Pharmacol Toxicol (2012) 3.83
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature (2012) 3.83
Crystal structure of a lipid G protein-coupled receptor. Science (2012) 3.78
Structure of the δ-opioid receptor bound to naltrindole. Nature (2012) 3.69
Structure of the human histamine H1 receptor complex with doxepin. Nature (2011) 3.48
Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev (2010) 3.27
Structure of the agonist-bound neurotensin receptor. Nature (2012) 3.23
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. Nature (2010) 3.19
Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol (2011) 3.15
Using sequence similarity networks for visualization of relationships across diverse protein superfamilies. PLoS One (2009) 3.03
Diversity and modularity of G protein-coupled receptor structures. Trends Pharmacol Sci (2011) 2.89
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex. Proc Natl Acad Sci U S A (2009) 2.86
Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure (2011) 2.84
Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations. Proc Natl Acad Sci U S A (2009) 2.77
The ID23-2 structural biology microfocus beamline at the ESRF. J Synchrotron Radiat (2009) 2.70
Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography. J Am Chem Soc (2010) 2.62
Overcoming barriers to membrane protein structure determination. Nat Biotechnol (2011) 2.49
Pathway and mechanism of drug binding to G-protein-coupled receptors. Proc Natl Acad Sci U S A (2011) 2.44
Biophysical dissection of membrane proteins. Nature (2009) 2.35
Micro-crystallography comes of age. Curr Opin Struct Biol (2012) 2.17
Structure determination of the seven-helix transmembrane receptor sensory rhodopsin II by solution NMR spectroscopy. Nat Struct Mol Biol (2010) 2.17
Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment. Structure (2011) 2.11
Ligand discovery from a dopamine D3 receptor homology model and crystal structure. Nat Chem Biol (2011) 2.10
Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery. J Med Chem (2012) 2.10
The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr Rev (2010) 2.09
Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure (2012) 2.08
Discovery of new GPCR biology: one receptor structure at a time. Structure (2009) 2.08
Crystal structure of oligomeric β1-adrenergic G protein-coupled receptors in ligand-free basal state. Nat Struct Mol Biol (2013) 2.06
Energy landscapes as a tool to integrate GPCR structure, dynamics, and function. Physiology (Bethesda) (2010) 2.05
Outcome of a workshop on applications of protein models in biomedical research. Structure (2009) 2.05
Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes. J Mol Recognit (2009) 2.05
Conserved waters mediate structural and functional activation of family A (rhodopsin-like) G protein-coupled receptors. Proc Natl Acad Sci U S A (2009) 2.01
Normal mode analysis of biomolecular structures: functional mechanisms of membrane proteins. Chem Rev (2010) 1.98
Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists. J Med Chem (2010) 1.88
Structural basis for molecular recognition at serotonin receptors. Science (2013) 1.86
Ligand-specific interactions modulate kinetic, energetic, and mechanical properties of the human β2 adrenergic receptor. Structure (2012) 1.85
G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody. Nature (2012) 1.82
Progress in structure based drug design for G protein-coupled receptors. J Med Chem (2011) 1.82
Thermostabilization of the neurotensin receptor NTS1. J Mol Biol (2009) 1.80
Nanobody stabilization of G protein-coupled receptor conformational states. Curr Opin Struct Biol (2011) 1.75
Two protonation switches control rhodopsin activation in membranes. Proc Natl Acad Sci U S A (2008) 1.74
Structure-based drug screening for G-protein-coupled receptors. Trends Pharmacol Sci (2012) 1.72
Structure-based discovery of A2A adenosine receptor ligands. J Med Chem (2010) 1.71
Ligand binding assays at equilibrium: validation and interpretation. Br J Pharmacol (2010) 1.71
CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4. J Biol Chem (2010) 1.69
Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody. Nature (2013) 1.68
Benchmarking membrane protein detergent stability for improving throughput of high-resolution X-ray structures. Structure (2011) 1.62
Structural basis of the interaction between chemokine stromal cell-derived factor-1/CXCL12 and its G-protein-coupled receptor CXCR4. J Biol Chem (2009) 1.60
A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor. J Biol Chem (2010) 1.59
Two distinct conformations of helix 6 observed in antagonist-bound structures of a beta1-adrenergic receptor. Proc Natl Acad Sci U S A (2011) 1.59
Membrane protein structure determination using crystallography and lipidic mesophases: recent advances and successes. Biochemistry (2012) 1.57
GPCR 3D homology models for ligand screening: lessons learned from blind predictions of adenosine A2a receptor complex. Proteins (2010) 1.57
Recent Advances in the Application of Solution NMR Spectroscopy to Multi-Span Integral Membrane Proteins. Prog Nucl Magn Reson Spectrosc (2009) 1.57
Overcoming the challenges of membrane protein crystallography. Curr Opin Struct Biol (2008) 1.57
Crystal structures of a stabilized β1-adrenoceptor bound to the biased agonists bucindolol and carvedilol. Structure (2012) 1.55
Ligand-dependent perturbation of the conformational ensemble for the GPCR β2 adrenergic receptor revealed by HDX. Structure (2011) 1.54
Thermostabilisation of an agonist-bound conformation of the human adenosine A(2A) receptor. J Mol Biol (2011) 1.54
N-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists. J Med Chem (2009) 1.52
The GPCR Network: a large-scale collaboration to determine human GPCR structure and function. Nat Rev Drug Discov (2012) 1.50
Lifting the lid on GPCRs: the role of extracellular loops. Br J Pharmacol (2012) 1.50
Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators. J Comput Aided Mol Des (2009) 1.48
Docking and chemoinformatic screens for new ligands and targets. Curr Opin Biotechnol (2009) 1.47
Structural insights into adrenergic receptor function and pharmacology. Trends Pharmacol Sci (2011) 1.42
Pharmacological modulation of chemokine receptor function. Br J Pharmacol (2012) 1.41
Ligand-directed signalling at beta-adrenoceptors. Br J Pharmacol (2010) 1.40
Action of molecular switches in GPCRs--theoretical and experimental studies. Curr Med Chem (2012) 1.40
The significance of G protein-coupled receptor crystallography for drug discovery. Pharmacol Rev (2011) 1.39
Structure-Activity Relationship Studies of N- and C-Terminally Modified Secretin Analogs for the Human Secretin Receptor. PLoS One (2016) 1.39
The impact of GPCR structures on pharmacology and structure-based drug design. Br J Pharmacol (2009) 1.38
Application of protein engineering to enhance crystallizability and improve crystal properties. Acta Crystallogr D Biol Crystallogr (2010) 1.38
GPRC6A mediates the non-genomic effects of steroids. J Biol Chem (2010) 1.38
Evaluation of homology modeling of G-protein-coupled receptors in light of the A(2A) adenosine receptor crystallographic structure. J Med Chem (2009) 1.38
Agonist-bound structure of the human P2Y12 receptor. Nature (2014) 1.36
Evolution-guided discovery and recoding of allosteric pathway specificity determinants in psychoactive bioamine receptors. Proc Natl Acad Sci U S A (2010) 1.32
Successful prediction of the intra- and extracellular loops of four G-protein-coupled receptors. Proc Natl Acad Sci U S A (2011) 1.30
Topology of class A G protein-coupled receptors: insights gained from crystal structures of rhodopsins, adrenergic and adenosine receptors. Mol Pharmacol (2008) 1.28
Modeling the possible conformations of the extracellular loops in G-protein-coupled receptors. Proteins (2010) 1.27
Structural basis of G protein-coupled receptor-G protein interactions. Nat Chem Biol (2010) 1.27
Recent progress in the structure determination of GPCRs, a membrane protein family with high potential as pharmaceutical targets. Methods Mol Biol (2010) 1.27
Opsin is a phospholipid flippase. Curr Biol (2011) 1.27
Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists. J Med Chem (2009) 1.26
Modern homology modeling of G-protein coupled receptors: which structural template to use? J Med Chem (2009) 1.26
A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors. J Biol Chem (2009) 1.25
Induced effects of sodium ions on dopaminergic G-protein coupled receptors. PLoS Comput Biol (2010) 1.25
The structural basis of G-protein-coupled receptor signaling (Nobel Lecture). Angew Chem Int Ed Engl (2013) 1.25
Mapping the druggable allosteric space of G-protein coupled receptors: a fragment-based molecular dynamics approach. Chem Biol Drug Des (2010) 1.24
Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteins. Mol Pharmacol (2010) 1.23
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
Phaser crystallographic software. J Appl Crystallogr (2007) 108.34
Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers (1983) 99.69
Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr (2005) 61.38
PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr (2002) 53.61
Crystal structure of rhodopsin: A G protein-coupled receptor. Science (2000) 28.60
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science (2007) 20.32
Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature (2007) 14.06
GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science (2007) 11.74
The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J Mol Biol (2004) 7.38
Structure of bovine rhodopsin in a trigonal crystal form. J Mol Biol (2004) 6.80
Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J (1999) 6.25
High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation. Proc Natl Acad Sci U S A (2008) 5.06
The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol (2005) 4.07
Conformational thermostabilization of the beta1-adrenergic receptor in a detergent-resistant form. Proc Natl Acad Sci U S A (2008) 3.77
Metal-ligand geometry relevant to proteins and in proteins: sodium and potassium. Acta Crystallogr D Biol Crystallogr (2002) 3.55
Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. J Biol Chem (1989) 3.51
Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J Biol Chem (2001) 3.49
International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev (2005) 3.33
Molecular mechanism of 7TM receptor activation--a global toggle switch model. Annu Rev Pharmacol Toxicol (2006) 3.33
Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide cross-linking. Adv Protein Chem (2003) 3.28
Crystal structure of a thermally stable rhodopsin mutant. J Mol Biol (2007) 2.80
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br J Pharmacol (2005) 2.73
Essential role for the second extracellular loop in C5a receptor activation. Nat Struct Mol Biol (2005) 2.71
The forgotten serine. A critical role for Ser-2035.42 in ligand binding to and activation of the beta 2-adrenergic receptor. J Biol Chem (2000) 2.67
An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J Mol Biol (1997) 2.66
The avian beta-adrenergic receptor: primary structure and membrane topology. Proc Natl Acad Sci U S A (1986) 2.45
Protein crystallography microdiffraction. Curr Opin Struct Biol (2005) 2.15
The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice. Proc Natl Acad Sci U S A (2004) 2.10
Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J Biol Chem (1997) 2.01
Expression and purification of truncated, non-glycosylated turkey beta-adrenergic receptors for crystallization. Biochim Biophys Acta (2003) 1.90
Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor. Mol Pharmacol (1994) 1.83
Critical role for the second extracellular loop in the binding of both orthosteric and allosteric G protein-coupled receptor ligands. J Biol Chem (2007) 1.70
Multiple residues in the second extracellular loop are critical for M3 muscarinic acetylcholine receptor activation. J Biol Chem (2007) 1.65
Reconstitutively active G protein-coupled receptors purified from baculovirus-infected insect cells. J Biol Chem (1991) 1.63
The second intracellular loop of the m5 muscarinic receptor is the switch which enables G-protein coupling. J Biol Chem (1998) 1.54
The role of the seventh transmembrane region in high affinity binding of a beta 2-selective agonist TA-2005. Mol Pharmacol (1998) 1.40
Site of action of beta-ligands at the human beta1-adrenoceptor. J Pharmacol Exp Ther (2005) 1.36
Ser203 as well as Ser204 and Ser207 in fifth transmembrane domain of the human beta2-adrenoceptor contributes to agonist binding and receptor activation. Br J Pharmacol (1999) 1.33
Chimeric muscarinic cholinergic: beta-adrenergic receptors that activate Gs in response to muscarinic agonists. J Biol Chem (1990) 1.32
Delineation of muscarinic receptor domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers. Mol Pharmacol (1990) 1.26
Identification of a key amino acid of the beta2-adrenergic receptor for high affinity binding of salmeterol. Mol Pharmacol (1998) 1.17
Conversion of agonist site to metal-ion chelator site in the beta(2)-adrenergic receptor. Proc Natl Acad Sci U S A (1999) 1.16
Beta(1)-selective agonist (-)-1-(3,4-dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(-)-RO363] differentially interacts with key amino acids responsible for beta(1)-selective binding in resting and active states. J Pharmacol Exp Ther (2002) 1.10
Chimeric muscarinic cholinergic:beta-adrenergic receptors that are functionally promiscuous among G proteins. J Biol Chem (1994) 1.04
Constitutively active mutants of the beta1-adrenergic receptor. FEBS Lett (1999) 1.01
Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr (2011) 67.55
iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr D Biol Crystallogr (2011) 18.13
Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature (2007) 14.06
Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J Mol Biol (2003) 12.04
Structure of bovine rhodopsin in a trigonal crystal form. J Mol Biol (2004) 6.80
Molecular signatures of G-protein-coupled receptors. Nature (2013) 5.19
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature (2011) 4.60
The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor. Nature (2011) 4.31
The structural basis of agonist-induced activation in constitutively active rhodopsin. Nature (2011) 3.79
Conformational thermostabilization of the beta1-adrenergic receptor in a detergent-resistant form. Proc Natl Acad Sci U S A (2008) 3.77
Structure of the rotor of the V-Type Na+-ATPase from Enterococcus hirae. Science (2005) 3.46
High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy. Ultramicroscopy (2013) 3.24
Structure of the agonist-bound neurotensin receptor. Nature (2012) 3.23
Beam-induced motion of vitrified specimen on holey carbon film. J Struct Biol (2012) 2.84
Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure (2011) 2.84
Crystal structure of a thermally stable rhodopsin mutant. J Mol Biol (2007) 2.80
Molecular basis of transmembrane signalling by sensory rhodopsin II-transducer complex. Nature (2002) 2.65
Electron crystallography reveals the structure of metarhodopsin I. EMBO J (2004) 2.63
Bioenergetic cost of making an adenosine triphosphate molecule in animal mitochondria. Proc Natl Acad Sci U S A (2010) 2.50
Overcoming barriers to membrane protein structure determination. Nat Biotechnol (2011) 2.49
Autoindexing diffraction images with iMosflm. Acta Crystallogr D Biol Crystallogr (2013) 2.25
Ground state structure of F1-ATPase from bovine heart mitochondria at 1.9 A resolution. J Biol Chem (2007) 2.19
The structure of bovine F1-ATPase inhibited by ADP and beryllium fluoride. EMBO J (2004) 2.08
New G-protein-coupled receptor crystal structures: insights and limitations. Trends Pharmacol Sci (2008) 2.06
Engineering G protein-coupled receptors to facilitate their structure determination. Curr Opin Struct Biol (2009) 1.93
On the structure of the stator of the mitochondrial ATP synthase. EMBO J (2006) 1.90
Expression and purification of truncated, non-glycosylated turkey beta-adrenergic receptors for crystallization. Biochim Biophys Acta (2003) 1.90
Three-dimensional structure of the bacterial multidrug transporter EmrE shows it is an asymmetric homodimer. EMBO J (2003) 1.90
Co-evolving stability and conformational homogeneity of the human adenosine A2a receptor. Proc Natl Acad Sci U S A (2008) 1.89
Novel features of the rotary catalytic mechanism revealed in the structure of yeast F1 ATPase. EMBO J (2006) 1.89
A dynamic analysis of the rotation mechanism for conformational change in F(1)-ATPase. Structure (2002) 1.84
Structure of the mitochondrial ATP synthase by electron cryomicroscopy. EMBO J (2003) 1.84
Structure of the adenosine A(2A) receptor bound to an engineered G protein. Nature (2016) 1.84
Thermostabilization of the neurotensin receptor NTS1. J Mol Biol (2009) 1.80
Tracking G-protein-coupled receptor activation using genetically encoded infrared probes. Nature (2010) 1.79
The structure of bovine F1-ATPase in complex with its regulatory protein IF1. Nat Struct Biol (2003) 1.78
The structure of the membrane extrinsic region of bovine ATP synthase. Proc Natl Acad Sci U S A (2009) 1.77
Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols. Proc Natl Acad Sci U S A (2007) 1.75
Protein crystallography with a micrometre-sized synchrotron-radiation beam. Acta Crystallogr D Biol Crystallogr (2008) 1.72
How the regulatory protein, IF(1), inhibits F(1)-ATPase from bovine mitochondria. Proc Natl Acad Sci U S A (2007) 1.67
How azide inhibits ATP hydrolysis by the F-ATPases. Proc Natl Acad Sci U S A (2006) 1.65
Two distinct conformations of helix 6 observed in antagonist-bound structures of a beta1-adrenergic receptor. Proc Natl Acad Sci U S A (2011) 1.59
Crystal structures of a stabilized β1-adrenoceptor bound to the biased agonists bucindolol and carvedilol. Structure (2012) 1.55
Thermostabilisation of an agonist-bound conformation of the human adenosine A(2A) receptor. J Mol Biol (2011) 1.54
Mass spectrometry of membrane transporters reveals subunit stoichiometry and interactions. Nat Methods (2009) 1.51
Quasi-symmetry in the cryo-EM structure of EmrE provides the key to modeling its transmembrane domain. J Mol Biol (2006) 1.47
Development and crystallization of a minimal thermostabilised G protein-coupled receptor. Protein Expr Purif (2009) 1.45
Excitement over X-ray lasers is excessive. Nature (2002) 1.44
Outrunning free radicals in room-temperature macromolecular crystallography. Acta Crystallogr D Biol Crystallogr (2012) 1.32
Molecular architecture and mechanism of an icosahedral pyruvate dehydrogenase complex: a multifunctional catalytic machine. EMBO J (2002) 1.30
Agonist-bound structures of G protein-coupled receptors. Curr Opin Struct Biol (2012) 1.23
Transferability of thermostabilizing mutations between beta-adrenergic receptors. Mol Membr Biol (2009) 1.22
Three-dimensional structure of TspO by electron cryomicroscopy of helical crystals. Structure (2010) 1.22
Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin. J Biol Chem (2004) 1.21
Asymmetric structure of the yeast F1 ATPase in the absence of bound nucleotides. J Biol Chem (2009) 1.20
Data management challenges in three-dimensional EM. Nat Struct Mol Biol (2012) 1.19
Opsin stability and folding: modulation by phospholipid bicelles. J Mol Biol (2007) 1.13
Structures of membrane proteins. Q Rev Biophys (2010) 1.11
Structural evidence of a new catalytic intermediate in the pathway of ATP hydrolysis by F1-ATPase from bovine heart mitochondria. Proc Natl Acad Sci U S A (2012) 1.11
Crystals of native and modified bovine rhodopsins and their heavy atom derivatives. J Mol Biol (2004) 1.09
Optimising the combination of thermostabilising mutations in the neurotensin receptor for structure determination. Biochim Biophys Acta (2013) 1.07
The three-dimensional structure of bovine rhodopsin determined by electron cryomicroscopy. J Biol Chem (2003) 1.05
New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells. J Med Chem (2007) 1.05
Molecular architecture of a retinal cGMP-gated channel: the arrangement of the cytoplasmic domains. EMBO J (2002) 1.03
Calreticulin promotes folding/dimerization of human lipoprotein lipase expressed in insect cells (sf21). J Biol Chem (2003) 1.03
Electron crystallography reveals plasticity within the drug binding site of the small multidrug transporter EmrE. J Mol Biol (2008) 1.02
Ni-chelate-affinity purification and crystallization of the yeast mitochondrial F1-ATPase. Protein Expr Purif (2004) 1.02
Recoverin binds exclusively to an amphipathic peptide at the N terminus of rhodopsin kinase, inhibiting rhodopsin phosphorylation without affecting catalytic activity of the kinase. J Biol Chem (2006) 1.01
Rhodopsin photoproducts in 2D crystals. J Mol Biol (2004) 1.01
An emerging consensus for the structure of EmrE. Acta Crystallogr D Biol Crystallogr (2009) 1.01
Thermostabilisation of the serotonin transporter in a cocaine-bound conformation. J Mol Biol (2013) 0.99
Two alternative conformations of a voltage-gated sodium channel. J Mol Biol (2013) 0.99
Biophysical fragment screening of the β1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug design. J Med Chem (2013) 0.99
Engineering an ultra-thermostable β(1)-adrenoceptor. J Mol Biol (2011) 0.99